Eli L. Diamond, MD
Neuro-Oncologist & Early Drug Development Specialist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Meet Neuro-Oncologist Eli Diamond
Video DetailsAbout Me
- Associate Attending Physician
I am a neuro-oncologist who specializes in the care of patients with brain tumors and the neurologic complications of cancer.
I work together with neurosurgeons and radiation oncologists to provide the highest quality medical treatment and supportive care for patients with gliomas and glioblastomas, primary central nervous system lymphomas (brain and spinal cord), ependymomas, and other types of brain tumors.
Read more
Together with my colleagues in the Memorial Sloan Kettering Counseling Center, I perform clinical research about quality of life, symptom management, and patient-physician communication for patients with brain tumors. I also participate in an interdisciplinary effort at Memorial Sloan Kettering to treat and study patients with histiocytic disorders such as Erdheim-Chester disease and Langerhans cell histiocytosis. My colleagues on this team include Drs. Raajit Rampal, and Mario Lacoutoure.
A neuro-oncologist is a doctor with special training in cancers that affect the brain, spinal cord, peripheral nerves, and muscles. This includes brain tumors and central nervous system tumors.
An early drug development specialist tests new drugs to treat cancer. They have special training in research studies, known as clinical trials.
My Specialties
- Neuro-Oncology
- Adult Brain Tumors
- Histiocytosis
Education
- MD, Albert Einstein College of Medicine
Residencies
- Neurology - Brigham and Women's Hospital/Massachsuetts General Hospital
Fellowships
- Neuro-Oncology - Memorial Sloan Kettering Cancer Center
Board Certifications
- Neurology
- Neuro-oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Dr. Diamond sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
See all Early Drug Development Service doctors
Clinical Trials
- Clinical Trials Investigated by Dr. Diamond
- A Phase 2 Study of Ulixertinib for People With Histiocytic Neoplasms
- Clinical Trials Co-Investigated by Dr. Diamond
- A Phase 1 Study of PF-07799933 Alone or with Binimetinib or Cetuximab in People with Solid Tumors
- A Phase I Study of AZD1390 plus Radiation Therapy in Patients with Glioblastoma Multiforme or Brain Metastases
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Diamond’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Eli L. Diamond discloses the following relationships and financial interests:
-
Histiocytosis Association, Inc.
Professional Services and Activities (Uncompensated) -
Opna Bio
Professional Services and Activities
-
Pfizer, Inc.
Professional Services and Activities (Uncompensated)
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].